The PTEN tumor suppressor inhibits telomerase activity in endometrial cancer cells by decreasing hTERT mRNA levels
Chunxiao Zhou(University of North Carolina at Chapel Hill), John F. Boggess(University of Kentucky), Victoria Bae‐Jump(University of North Carolina at Chapel Hill), Young E. Whang(University of North Carolina at Chapel Hill), Paola A. Gehrig(University of North Carolina at Chapel Hill)
Cited by 50
Related Papers
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study
|The Lancet Oncology|2017|929
Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
|Journal of Clinical Oncology|2004|644
A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomy
|American Journal of Obstetrics and Gynecology|2008|458